FN2 Earnings Intelligence
CME revenue earnings history
CME Group Inc. (CME) quarterly reported and estimated revenue history by fiscal quarter.
Earnings History
CME Group Inc.
The supplied analysis supports a constructive operating thesis for CME: strong volume, international expansion, product innovation and margin-efficiency initiatives can support continued growth. The thesis depends on regulatory progress, sustained market activity and successful execution of the technology and clearing roadmap.
CME Group Inc.
CME Group delivered record Q2 2026 revenue of $1.71B (+1.4% vs consensus) and EPS of $2.99 (+2.7% surprise), with near-historical daily contract volume driven by 94% institutional participation. The stock surged 5.0% on the print with continued positive drift of +4.3% afterward. Management maintained guidance and outlined a robust product pipeline: 24/7 crypto and gold futures, Single Stock futures, Compute Futures tied to NVIDIA H100 GPU rental costs, and Treasury Link for Q4 2026. Market-data revenue grew 20% YoY. The primary overhang is ongoing CFTC litigation, with the agency's response expected in August, creating uncertainty around 24/7 and perpetual futures offerings. The bullish score moderated to 78 from 88 last quarter, reflecting regulatory uncertainty and the absence of a capex outlook. With analyst consensus at $304 versus a current price of $260, the market is weighing…
CME Group Inc.
CME's quarter supports a constructive operating narrative: record activity, international growth and new clearing and digital products broaden its growth drivers. The counterweight is execution and regulatory risk, while the supplied analysis does not include prior-quarter analysis for a direct trend comparison.
CME Group Inc.
The supplied analysis supports a constructive but qualified view: strong activity, product innovation, retail expansion, and international demand provide growth support, while regulation, volatility, and execution remain material tests.
CME Group Inc.
The supplied analysis supports a constructive but qualified view: strong volume demand, retail participation and international growth reinforce CME’s earnings-growth narrative, while regulatory, macroeconomic and execution risks limit certainty.
CME Group Inc.
The supplied analysis supports a constructive but qualified view: record volume, international expansion, retail distribution, and product launches reinforce CME's growth trajectory, while margin changes, regulatory execution, competition, and the absence of reported-versus-consensus actuals limit confidence.
CME Group Inc.
The analysis supports a constructive but conditional view of CME’s operating trajectory: record activity, retail distribution, product expansion, and technology investment support continued growth, while regulatory execution, competition, fee changes, and capital-allocation questions are material counterweights.
CME Group Inc.
The quarter supports a constructive operating thesis: record volume, international expansion, crypto-futures adoption and client acquisition are reinforcing growth. That support is balanced by competition, regulatory uncertainty, possible RPC pressure and higher licensing costs.
Get the CME recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.